In Vitro Diagnostic Industry: A Review of The Unsung Hero of Precise Clinical Decision Making

In vitro diagnostic solutions are the behind-the-scenes hero of healthcare, quietly working to help diagnose and manage variety of health issues. The blog below includes information about these solutions, the latest trends in this market and how such solutions help to diagnose and detect disease conditions. In addition to the healthcare providers, the stakeholders in the in vitro diagnostic industry are playing an equally important role for patients, as accurate and timely diagnostic information can make all the difference in treatment outcomes and overall health.

What are In Vitro Diagnostic Tests?

In vitro diagnostic tests are conducted on samples retrieved from human body, such as blood, saliva or tissue in order to detect various diseases or conditions. Such tests help diagnose, monitor, and manage diseases, such as diabetes, infectious diseases, and cancer. The common types of IVD tests include immunoassays, molecular diagnostics, and clinical chemistry tests. Such tests play a crucial role in healthcare by providing timely and accurate information for medical decision-making. In vitro diagnostic tests are essential tools for screening, diagnosing, and monitoring diseases, ultimately contributing to improved patient outcomes and public health.

In terms of regulatory frameworks, the in vitro diagnostic solutions have been classified into four classes: Class A, Class B, Class C and Class D. This classification is crucial for regulatory purposes and understanding the level of risk associated with each device. Such classifications are determined by the various regulatory bodies, such as the FDA in the United States or the European Union’s CE marking system which help ensure that appropriate regulatory controls are applied to maintain safety and efficacy standards.

Understanding the classification of IVD devices is essential for manufacturers to navigate the regulatory pathway for bringing their products to market and for healthcare professionals to ensure the safety and reliability of diagnostic testing in clinical practice. Here’s a breakdown of the typical classification of devices within the in vitro diagnostic industry:

Types of In Vitro Diagnostic Tests

In the following section, we explore the various types of tests within in vitro diagnostic industry:

• Immunoassay Tests – These tests detect the presence of specific molecules, typically proteins or antibodies, in a sample using the reaction between an antigen and an antibody. Some of the examples include enzyme immunoassays, radioimmunoassay, and chemiluminescence immunoassay.
• Molecular Diagnostic Tests – These tests detect and analyze nucleic acids (DNA or RNA) to identify genetic variations, pathogens, or mutations. Some of the examples include polymerase chain reaction (PCR), next-generation sequencing (NGS), microarrays, and in situ hybridization.
• Clinical Chemistry Tests – These tests analyze chemical components in bodily fluids like blood or urine to assess organ function, diagnose diseases, and monitor treatment responses. Some of the examples include, blood glucose test, liver function tests, lipid profile tests.
• Microbiological Tests – These tests identify and characterize microorganisms like bacteria, viruses, fungi, and parasites in clinical samples. Some of the examples include culture and sensitivity tests, antimicrobial susceptibility tests.
• Point-of-Care Testing – Point-of-care tests are the tests that provide rapid results at or near the patient’s location, thus enabling timely clinical decisions. Some of the examples include, rapid antigen tests, blood gas analysis, hCG-based pregnancy tests, glucose monitoring.

Therapeutic Areas Targeted by In Vitro Diagnostic Tests

In the following sections, we explore the various therapeutic areas targeted by In Vitro Diagnostic Tests.

• Infectious Disease – In vitro diagnostic solutions can be used to diagnose a variety of infectious diseases. For example, for HIV / AIDS, a variety of HIV antibody tests and viral load detection tests are available in the domain. On the other hand, for diseases, such as Hepatitis, a variety of surface antigen tests and Hepatitis C antibody tests are available in the market.
• Cancer Diagnostics – In vitro diagnostic solutions serve as critical tools for early detection and management of oncological disorders. can be used to diagnose a variety of infectious diseases. Some of the examples include HER2/neu tests and estrogen receptor / progesterone receptor tests for breast cancer detection and faecal occult tests for colorectal cancer.

• Cardiovascular Diseases – In vitro diagnostic solutions find their application in the diagnosis of various cardiovascular diseases. For example, cardiac biomarkers and troponin tests, lipid profile and cholesterol / triglyceride tests.
• Autoimmune Disorders – In vitro diagnostic solutions are equally essential for the diagnosis of autoimmune diseases. For example, rheumatoid factor tests, anti-cyclic citrullinated peptide tests and antinuclear antibody tests for systemic lupus erythematosus.
• Neurological Disorders – Many of the in vitro diagnostic solutions are pivotal in the diagnosis and management of neurological disorders. Some of the examples include amyloid beta (Aβ) protein tests and tau protein tests for Alzheimer’s disease and oligoclonal banding tests in cerebrospinal fluid for multiple sclerosis.
• Pregnancy and Fertility – In vitro diagnostic solutions find a variety of applications in the areas of pregnancy and fertility. For example, urine-based hCG tests for rapid pregnancy detection test, ovulation predictor kits and sperm analysis tests.

Recent Developments in the In Vitro Diagnostics Industry

Below, we have mentioned recent developments made in this domain:

• In April 2024, Roche Diagnostics announced the launch of its cancer diagnostics test in China, titled Elecsys CA 242 assay, intended to diagnose pancreatic cancer and colorectal cancer.
• In March 2024, CleanNA launched Clean Quick Viral DNA/RNA which claims to extract viral DNA and RNA from nasopharyngeal or oropharyngeal swab samples along with its CleanXtract 96 or general liquid handlers.
• In January 2024, the EU commission revised the in vitro diagnostics regulation (IVDR) in order to improve the transparency in the diagnostics domain and to enhance patient care while aiming to improve the availability of such healthcare products.

In vitro diagnostic (IVD) tests find a variety of applications across various medical domains, including cancer, autoimmune disorders, neurological conditions, and reproductive health. These diagnostic tools offer a variety of applications such as early detection, precise diagnosis, and effective monitoring of diseases, in order to facilitate timely and precise diagnosis. Despite several challenges, such as cost and accessibility, the ongoing technological evolution within in vitro diagnostic industry will drive greater precision and broader application in healthcare.

Author Bio:
Gaurav Raj Bangarh

Gaurav Raj Bangarh is a market research analyst and competitive intelligence professional. He is highly skilled at generating useful insights from unstructured / structured datasets. As a senior analyst at Roots Analysis, Gaurav has assisted several clients across multiple industry verticals within the healthcare domain. These verticals include, medical devices / technologies, digital healthcare services and various drugs / disease indications.
Gaurav holds a B. Tech degree in Biotechnology from Lovely Professional University. In addition to working on market research and pharmaceutical business analysis, he has hands-on laboratory experience and has worked at esteemed research institutes of India, such as CSIR-CFTRI, Mysore. To date, he has contributed to over eight full length market research projects and consulting projects.